Adoptive immunotherapy of ovarian carcinoma

Gynecologic Oncology

Volumn 86, Issue 1, 2002, Pages 102-103

  De Gramont, A ^a   Gangji, D ^b   Louvet, C ^a   Garcia, M L ^a   Tardy, D ^c   Romet Lemonne, J L ^c  

^a HÔPITAL SAINT ANTOINE   (France)

^b ERASME HOSPITAL   (Belgium)

^c Immuno Designed Molecules   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CA 125 ANTIGEN; FC RECEPTOR; GAMMA INTERFERON; MONOCLONAL ANTIBODY; TUMOR MARKER;

APHERESIS; CANCER IMMUNOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; FEMALE; HUMAN; KILLER CELL; LETTER; MACROPHAGE; METASTASIS; MONONUCLEAR CELL; OVARY CANCER; PRIORITY JOURNAL; PROGNOSIS; PROTO ONCOGENE;

EID: 0036314356     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.2002.6667     Document Type: Editorial

References (5)

1. Macrophages and metastasis: A biological approach to cancer therapy
2. Pathogenesis of ovarian cancers
3. Phase I trial of bispecific antibody MDX-H210 in patients with advanced breast or ovarian cancer that overexpresses the proto-oncogene HER-2/neu
4. Large scale isolation of human blood monocytes by continuous flow centrifugation leukapheresis and counterflow centrifugation elutriation for adoptive cellular immunotherapy in cancer patients